Board Member
Radnostix Inc (INIS)Equibles does not estimate personal net worth.
Get an email with a short summary when Radnostix Inc publishes a filing, an earnings call transcript or a press release.
Get INIS alertsShahe Bagderjian is recorded as CEO at Radnostix Inc (INIS) since September 1, 2023 and Board Member at Radnostix Inc (INIS) since July 12, 2023. Radnostix Inc reported in an 8-K filed July 18, 2023 that Shahe Bagderjian was appointed Chief Executive Officer, effective September 1, 2023. Radnostix Inc reported in an 8-K filed July 18, 2023 that Shahe Bagderjian was appointed director, effective July 12, 2023. Radnostix Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Radnostix Inc includes Shahe Bagerdjian (CEO and Board Member), Laurie McKenzie-Carter (CFO), W. Matthew Cox (CFO) and 6 others.
“In addition, on July 12, 2023, Shahe Bagderjian, President of the Company, was appointed to replace Mr. Laflin as Chief Executive Officer, effective September 1, 2023.”
“On July 12, 2023, the Board, pursuant to the Restated Certificate of Formation of the Company and the Bylaws of the Company, approved an increase of the size of the Board from three directors to four directors, and appointed Shahe Bagderjian to serve as a director on the Board, effectively immediately.”
2023-09-01–present
2023-07-12–present
INIS
Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
2023-07-12–present
